Scientific and Clinical Publications

Explore Siemens Healthineers' scientific and clinical publications, a collection that offers clinical perspectives and scientific insights from nuclear medicine and molecular imaging leaders.

Linda Brookes

Fluoroestradiol F 18 – a molecular marker becomes commercially available for PET imaging in metastatic breast cancer

A new radiopharmaceutical agent was approved by the FDA for use with PET imaging: Fluoroestradiol F 18 (FES). Known in the U.S. as Cerianna™, it is an estrogen analog and the first F-18 PET imaging agent indicated for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.

Ethan Colliver, DO

The use of SPECT/CT in a musculoskeletal Physical Medicine and Rehabilitation practice

Ethan Colliver, DO, shares his insight and clinical experience using SPECT/CT in the detection and diagnosis process, and why he feels the utilization of nuclear medicine may result in more targeted and effective treatments.